| Title | Description | ||||||
|---|---|---|---|---|---|---|---|
| Active Ingredients |
|
||||||
| Dosage Form | TABLET, FILM COATED | ||||||
| Packaging | 1 DOSE PACK in 1 CARTON (0074-2625-01) > 3 TABLET, FILM COATED in 1 DOSE PACK, 4 CARTON in 1 CARTON (0074-2625-28) > 7 DOSE PACK in 1 CARTON > 3 TABLET, FILM COATED in 1 DOSE PACK, 2 CARTON in 1 CARTON (0074-2625-56) > 4 CARTON in 1 CARTON > 7 DOSE PACK in 1 CARTON > 3 TABLET, FILM COATED in 1 DOSE PACK, 84 TABLET, FILM COATED in 1 BOTTLE (0074-2625-80), 84 TABLET, FILM COATED in 1 BOTTLE (0074-2625-84), | ||||||
| Pharm Type | Breast Cancer Resistance Protein Inhibitors [MoA], Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], HCV NS3/4A Protease Inhibitors [MoA], Hepatitis C Virus NS3/4A Protease Inhibitor [EPC], Hepatitis C Virus NS5A Inhibitor [EPC], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], UGT1A1 Inhibitors [MoA], UGT1A1 Inhibitors [MoA] |